Disculpa, pero esta entrada está disponible sólo en Inglés Estadounidense. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.
Brimonidine gel (Mirvaso▼): risk of exacerbation of rosacea
Some patients may have exacerbation or rebound symptoms of rosacea.
Show your support for reporting suspected adverse drug reactions
We are running a social media campaign to promote the reporting of suspected adverse drug reactions to the Yellow Card Scheme in support of an awareness week from 7 to 11 November 2016.
Letters sent to healthcare professionals in October 2016
A summary of recent safety letters sent to relevant healthcare professionals